MedMira Inc (MIR : TSX-V)
Common Stock
$0.07
CAD
+0.01 (7.69%)
Last updated: 2026-07-13
MIR
MedMira Inc
WealthAwesomePerformance
1 Day
+7.69%
1 Week
+7.69%
1 Month
+7.69%
YTD
+7.69%
Key Statistics
Market Cap
$45.61M
52W High
$0.11
52W Low
$0.05
P/E Ratio
-
50 Day MA
$0.06
200 Day MA
$0.07
Beta
0.79
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/13/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 117,488 |
| 7/10/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 25,462 |
| 7/9/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 93,462 |
| 7/8/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 107,462 |
| 7/7/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 3,000 |
| 7/6/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 100,000 |
| 7/3/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 36,999 |
| 7/2/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 0 |
| 6/30/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 121,500 |
| 6/29/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 200,400 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MIR's historical volatility
30-Day Vol
91.7%
Annualized
90-Day Vol
102.6%
Annualized
Trend (90d)
+31.1%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.05 – C$0.10 |
| 60 trading days | C$0.08 | C$0.05 – C$0.12 |
| 90 trading days | C$0.08 | C$0.05 – C$0.14 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About MedMira Inc
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
Financials
- Revenue (TTM)
- $370,568
- EBITDA
- $-1.94M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- 0.00
- Book Value
- -0.04
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About MIR
Articles Featuring MIR.V
Latest articles and analysis covering MIR.V
Why MedMira Inc stock is skyrocketing today
MedMira Inc's stock soared by 7.69% today, closing at CA$0.07, reflecting investor optimism following recent financial results and product approvals.
Why MedMira Inc stock is plummeting today
MedMira Inc's stock plummeted by 7.14% today, closing at CA$0.07, as investors react to a lack of encouraging news following its recent earnings report. This decline raises questions about the company's financial stability and future growth potential.
Why MedMira Inc stock is plummeting today
MedMira Inc. (MIR.V) has faced a challenging trading day, with its stock price plummeting by 7.14%. This decline raises questions about the company's future, especially in light of its recent product developments and market position.
Why MedMira Inc stock is plummeting today
MedMira Inc. (MIR.V) experienced a sharp decline of 7.14% in its stock price, closing at CA$0.07. This drop raises questions about investor confidence, even as the company continues to innovate and expand its product offerings.
